Safety and immunogenicity data are not yet available in children above 5 years of age.Children with impaired immune responsiveness, whether due to the use of immunosuppressive therapy, a genetic defect, HIV infection, or other causes, may have reduced antibody response to vaccination.Safety and immunogenicity data in children with increased risk for pneumococcal infections (e.g. sickle cell diseas